» Articles » PMID: 37568498

Sex-Based Differences in Clinical Characteristics and Outcomes Among Patients with Peripheral Artery Disease: A Retrospective Analysis

Abstract

Peripheral arterial disease (PAD) is a prevalent medical condition associated with high mortality and morbidity rates. Despite the high clinical burden, sex-based differences among PAD patients are not well defined yet, in contrast to other atherosclerotic diseases. This study aimed to describe sex-based differences in clinical characteristics and outcomes among hospitalized patients affected by PAD. This was a retrospective study evaluating all patients with a diagnosis of PAD admitted to the Emergency Department from 1 December 2013 to 31 December 2021. The primary endpoint of the study was the difference between male and female PAD patients in cumulative occurrence of Major Adverse Cardiovascular Events (MACEs) and Major Adverse Limb Events. A total of 1640 patients were enrolled. Among them, 1103 (67.3%) were males while females were significantly older (median age of 75 years vs. 71 years; =< 0.001). Females underwent more angioplasty treatments for revascularization than men (29.8% vs. 25.6%; = 0.04); males were treated with more amputations (19.9% vs. 15.3%; = 0.012). A trend toward more MALEs and MACEs reported in the male group did not reach statistical significance (OR 1.27 [0.99-1.64]; = 0.059) (OR 0.75 [0.50-1.11]; = 0.153). However, despite lower extremity PAD severity seeming similar between the two sexes, among these patients males had a higher probability of undergoing lower limb amputations, of cardiovascular death and of myocardial infarction. Among hospitalized patients affected by PAD, even if there was not a sex-based significant difference in the incidence of MALEs and MACEs, adverse clinical outcomes were more common in males.

Citing Articles

A Non-Coronary, Peripheral Arterial Atherosclerotic Disease (Carotid, Renal, Lower Limb) in Elderly Patients-A Review: Part I-Epidemiology, Risk Factors, and Atherosclerosis-Related Diversities in Elderly Patients.

Piechocki M, Przewlocki T, Pieniazek P, Trystula M, Podolec J, Kablak-Ziembicka A J Clin Med. 2024; 13(5).

PMID: 38592280 PMC: 10935176. DOI: 10.3390/jcm13051471.

References
1.
Freisinger E, Malyar N, Reinecke H, Unrath M . Low rate of revascularization procedures and poor prognosis particularly in male patients with peripheral artery disease - A propensity score matched analysis. Int J Cardiol. 2018; 255:188-194. DOI: 10.1016/j.ijcard.2017.12.054. View

2.
Lee M, Choi B, Hollowed J, Han S, Baek M, Ryu Y . Assessment of Sex Differences in 5-Year Clinical Outcomes Following Endovascular Revascularization for Peripheral Artery Disease. Cardiovasc Revasc Med. 2019; 21(1):110-115. DOI: 10.1016/j.carrev.2019.03.018. View

3.
Biscetti F, Ferraro P, Hiatt W, Angelini F, Nardella E, Cecchini A . Inflammatory Cytokines Associated With Failure of Lower-Extremity Endovascular Revascularization (LER): A Prospective Study of a Population With Diabetes. Diabetes Care. 2019; 42(10):1939-1945. DOI: 10.2337/dc19-0408. View

4.
Song P, Rudan D, Zhu Y, Fowkes F, Rahimi K, Fowkes F . Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis. Lancet Glob Health. 2019; 7(8):e1020-e1030. DOI: 10.1016/S2214-109X(19)30255-4. View

5.
Biscetti F, Bonadia N, Santini F, Angelini F, Nardella E, Pitocco D . Sortilin levels are associated with peripheral arterial disease in type 2 diabetic subjects. Cardiovasc Diabetol. 2019; 18(1):5. PMC: 6329108. DOI: 10.1186/s12933-019-0805-5. View